Unhealthy Diet, Smoking, Obesity and Sedentary Lifestyle Driving Rapid Rise in Cancer Worldwide

Pierre Fabre İlaç Turkey General Manager Dr. Hande Demirdere: "Early Diagnosis and Correct Treatment Save Lives in Cancer"

Cancer, the disease of our time, ranks among the leading causes of death worldwide. Dr. Hande Demirdere, General Manager of Pierre Fabre İlaç, which has attracted attention with its research in bladder and skin cancer globally,

made a statement on the occasion of Cancer Awareness Week, noting that bladder cancer, one of the most frequently seen cancer types today, is detected particularly in men aged 65 and over with a history of tobacco use and high genetic predisposition. "The initial signs of bladder cancer include pain and bleeding during urination.

In some patients, this bleeding in the urine may appear as clots.

Additionally, regarding the risk of Malignant Melanoma, an important skin cancer, attention should be paid to moles on the body and they should be examined regularly. People with such complaints should consult specialists without delay," he said.

Emphasizing the importance of early diagnosis in cancer treatment, Demirdere stated, "As with other types of cancer, early diagnosis in bladder and skin cancer saves lives.

Patients in risk groups undergoing necessary tests at regular intervals and being monitored contributes to early diagnosis of these conditions. The fact that correct treatment following an early-stage diagnosis is life-saving is the notable point in these cancer cases," he said.

Drawing attention to the fundamental causes of cancer being diet, tobacco use and obesity, Pierre Fabre İlaç Turkey General Manager Dr. Hande Demirdere stated, "The sedentary lifestyle resulting from work patterns, continuous computer use pose a threat not only for today but also for future generations.

According to the World Cancer Report, cancer is projected to become the leading cause of death by 2030, with cancer cases increasing by 50%, resulting in 15 million people being diagnosed with cancer each year," he said.

Stating that as a pharmaceutical company serving human health, their primary responsibility is to provide treatment options to cancer patients and to ease and contribute to recovery from the difficult disease and treatment process, Pierre Fabre İlaç Turkey General Manager Dr. Hande Demirdere said, "With our patient-focused approach, we aim to strengthen our experience gained over the years with global partnerships to add new drugs to our treatment areas in order to better meet the needs of patients in Turkey."